Logo image of BMNR

BITMINE IMMERSION TECHNOLOGI (BMNR) Stock Fundamental Analysis

NYSEARCA:BMNR - NYSE Arca - US09175A1079 - Common Stock - Currency: USD

4.265  -0.16 (-3.51%)

Fundamental Rating

0

Overall BMNR gets a fundamental rating of 0 out of 10. We evaluated BMNR against 284 industry peers in the Software industry. BMNR has a bad profitability rating. Also its financial health evaluation is rather negative. BMNR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BMNR has reported negative net income.
BMNR had a negative operating cash flow in the past year.
BMNR had negative earnings in each of the past 5 years.
BMNR had a negative operating cash flow in each of the past 5 years.
BMNR Yearly Net Income VS EBIT VS OCF VS FCFBMNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

BMNR has a Return On Assets of -87.46%. This is amonst the worse of the industry: BMNR underperforms 88.73% of its industry peers.
BMNR has a worse Return On Equity (-229.93%) than 81.69% of its industry peers.
Industry RankSector Rank
ROA -87.46%
ROE -229.93%
ROIC N/A
ROA(3y)-33.47%
ROA(5y)-41.7%
ROE(3y)-49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMNR Yearly ROA, ROE, ROICBMNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 16.39%, BMNR is doing worse than 83.10% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for BMNR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMNR Yearly Profit, Operating, Gross MarginsBMNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

BMNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BMNR has been increased compared to 1 year ago.
The debt/assets ratio for BMNR is higher compared to a year ago.
BMNR Yearly Shares OutstandingBMNR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
BMNR Yearly Total Debt VS Total AssetsBMNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -2.54, we must say that BMNR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.54, BMNR is doing worse than 78.17% of the companies in the same industry.
A Debt/Equity ratio of 0.90 indicates that BMNR is somewhat dependend on debt financing.
BMNR has a worse Debt to Equity ratio (0.90) than 70.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z -2.54
ROIC/WACCN/A
WACC8.29%
BMNR Yearly LT Debt VS Equity VS FCFBMNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.25 indicates that BMNR may have some problems paying its short term obligations.
BMNR's Current ratio of 0.25 is on the low side compared to the rest of the industry. BMNR is outperformed by 95.07% of its industry peers.
A Quick Ratio of 0.25 indicates that BMNR may have some problems paying its short term obligations.
The Quick ratio of BMNR (0.25) is worse than 94.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
BMNR Yearly Current Assets VS Current LiabilitesBMNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

BMNR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.28%.
Looking at the last year, BMNR shows a very strong growth in Revenue. The Revenue has grown by 158.36%.
EPS 1Y (TTM)-100.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.33%
Revenue 1Y (TTM)158.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%70.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMNR Yearly Revenue VS EstimatesBMNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BMNR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMNR Price Earnings VS Forward Price EarningsBMNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMNR Per share dataBMNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BMNR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BITMINE IMMERSION TECHNOLOGI

NYSEARCA:BMNR (6/27/2025, 8:04:03 PM)

4.265

-0.16 (-3.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.75%
Ins Owner Change0%
Market Cap8.74M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.89
P/FCF N/A
P/OCF N/A
P/B 3.06
P/tB 3.06
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS2.26
BVpS1.39
TBVpS1.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -87.46%
ROE -229.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.39%
FCFM N/A
ROA(3y)-33.47%
ROA(5y)-41.7%
ROE(3y)-49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.43%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z -2.54
F-Score3
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)65716%
Cap/Depr(5y)N/A
Cap/Sales(3y)508.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)158.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%70.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y95.32%
OCF growth 3YN/A
OCF growth 5YN/A